Story perspectives

Hims & Hers Misses Q4 Revenue, Plans Global Expansion

2/24/2026

Summary

Story summary

Hims & Hers Health, Inc. reported fourth-quarter 2025 revenue of $617.82 million, below estimates of $619.22 million.
The company posted earnings per share of $0.08.
For the first quarter, revenue is forecast at $600 million to $625 million.
The company’s stock has fallen 52% this year due to regulatory issues around weight-loss products.
The company plans international expansion and diversification, including the acquisition of Australian digital health company Eucalyptus.

1 of 1

Story summary

Hims & Hers Health, Inc. reported fourth-quarter 2025 revenue of $617.82 million, below estimates of $619.22 million.
The company posted earnings per share of $0.08.
For the first quarter, revenue is forecast at $600 million to $625 million.
The company’s stock has fallen 52% this year due to regulatory issues around weight-loss products.
The company plans international expansion and diversification, including the acquisition of Australian digital health company Eucalyptus.